CalciMedica is trading 5.35% down at $1.77 as broader risk-off pressure hits biotechnology and growth stocks.
- The biotech XBI sector is down 2.04%, while major indexes are also lower.
- Rising crude oil prices, inflation concerns and Treasury yields are weighing on valuations.
- No company-specific announcement dated September 23, 2026 was identified; its latest listed release concerns an investor conference.